Pamidronate disodium injection is indicated for the treatment of hypercalcemia associated with malignancy and Paget’s disease.
Arthur Przybyl, president and CEO of Akorn and member manager of Akorn-Strides, said: “We are pleased to announce the abbreviated new drug application approval for pamidronate disodium injection.”